During the past decade, Northside Hospital-Alpharetta conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Northside Hospital-Alpharetta" #1 collaborator was "National Cancer Institute (NCI)" with 3 trials as a collaborator and "Canadian Cancer Trials Group" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Northside Hospital-Alpharetta" are "Ductal Breast Carcinoma" (1 trials), "Extensive Stage Lung Small Cell Carcinoma" (1 trials), "Invasive Breast Carcinoma" (1 trials), "Limited Stage Lung Small Cell Carcinoma" (1 trials) and "Lobular Breast Carcinoma" (1 trials). Many other conditions were trialed in "Northside Hospital-Alpharetta" in a lesser frequency.

Most popular intervention types in "Northside Hospital-Alpharetta" are "Other" (2 trials), "Radiation" (2 trials), "Drug" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Endocrine Therapy (Tamoxifen, Anastrozol, Letrozole, Exemestane)" (1 trials), "Hypofractionated Radiation Therapy" (1 trials), "Laboratory Biomarker Analysis" (1 trials), "Magnetic Resonance Imaging" (1 trials) and "Prophylactic Cranial Irradiation" (1 trials). Other intervention names were less common.

The vast majority of trials in "Northside Hospital-Alpharetta" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Northside Hospital-Alpharetta". undefined are not yet recruiting, 2 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Northside Hospital-Alpharetta, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Northside Hospital-Alpharetta, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".